Sluyter John D, Hughes Alun D, Lowe Andrew, Parker Kim H, Camargo Carlos A, Hametner Bernhard, Wassertheurer Siegfried, Scragg Robert K R
School of Population Health, University of Auckland, Auckland, New Zealand.
Institute of Cardiovascular Sciences, University College London, London, UK.
Int J Cardiol. 2016 Sep 15;219:257-63. doi: 10.1016/j.ijcard.2016.06.051. Epub 2016 Jun 15.
Comparing the relationships of antihypertensive medications with brachial blood pressure (BP) and aortic waveform parameters may help clinicians to predict the effect on the latter in brachial BP-based antihypertensive therapy. We aimed to make such comparisons with new waveform measures and a wider range of antihypertensive regimens than examined previously.
Cross-sectional analysis of 2933 adults (61% male; aged 50-84years): 1637 on antihypertensive treatment and 1296 untreated hypertensives. Sixteen medicine regimens of up to 4 combinations of drugs from 6 antihypertensive classes were analysed. Aortic systolic BP, augmentation index (AIx), excess pressure integral (EPI), backward pressure amplitude (Pb), reflection index (RI) and pulse wave velocity (PWV) were calculated from aortic pressure waveforms derived from suprasystolic brachial measurement.
Forest plots of single-drug class comparisons across regimens with the same number of drugs (for between 1- and 3-drug regimens) revealed that AIx, Pb, RI and/or loge(EPI) were higher (maximum difference=5.6%, 2.2mmHg, 0.0192 and 0.13 loge(mmHg⋅s), respectively) with the use of a beta-blocker compared with vasodilators and diuretics, despite no brachial systolic and diastolic BP differences. These differences were reduced (by 34-57%) or eliminated after adjustment for heart rate, and similar effects occurred when controlling for systolic ejection period or diastolic duration.
Beta-blocker effects on brachial BP may overestimate effects on aortic waveform parameters. Compared to other antihypertensives, beta-blockers have weaker associations with wave reflection measures and EPI; this is predominantly due to influences on heart rate.
比较抗高血压药物与肱动脉血压(BP)和主动脉波形参数之间的关系,可能有助于临床医生预测基于肱动脉血压的抗高血压治疗对后者的影响。我们旨在使用新的波形测量方法和比以往研究更广泛的抗高血压治疗方案进行此类比较。
对2933名成年人(61%为男性;年龄50 - 84岁)进行横断面分析:1637名接受抗高血压治疗,1296名未治疗的高血压患者。分析了来自6类抗高血压药物的多达4种药物组合的16种药物治疗方案。根据超收缩期肱动脉测量得出的主动脉压力波形计算主动脉收缩压、增强指数(AIx)、过压积分(EPI)、反向压力幅度(Pb)、反射指数(RI)和脉搏波速度(PWV)。
在相同药物数量的治疗方案(1 - 3种药物治疗方案)中,单药类比较的森林图显示,与血管扩张剂和利尿剂相比,使用β受体阻滞剂时AIx、Pb、RI和/或ln(EPI)更高(最大差异分别为5.6%、2.2mmHg、0.0192和0.13ln(mmHg·s)),尽管肱动脉收缩压和舒张压无差异。在调整心率后,这些差异减小(降低34 - 57%)或消除,在控制收缩期射血期或舒张期持续时间时也出现类似效果。
β受体阻滞剂对肱动脉血压的影响可能高估了对主动脉波形参数的影响。与其他抗高血压药物相比,β受体阻滞剂与波反射测量和EPI的关联较弱;这主要是由于对心率的影响。